n-methyladenosine has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LJ; Huang, SF; Peng, XF; Xu, L; Ye, WC | 1 |
| Sheng, B; Sun, Y; Wu, X; Xu, K; Zheng, Y | 1 |
2 review(s) available for n-methyladenosine and Liver Dysfunction
| Article | Year |
|---|---|
Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics.
Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Liver Diseases; Risk Factors; RNA, Long Noncoding | 2021 |
Role of identified RNA N6-methyladenosine methylation in liver.
Topics: Adenosine; Eukaryota; Liver; Liver Diseases; Methylation; MicroRNAs; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; RNA, Messenger; Viruses | 2019 |